Bluejay Diagnostics Files 8-K Report
Ticker: BJDX · Form: 8-K · Filed: 2025-08-11T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Bluejay Diagnostics filed an 8-K, likely containing important updates for investors.
AI Summary
On August 7, 2025, Bluejay Diagnostics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself are detailed in the provided text.
Why It Matters
This 8-K filing indicates that Bluejay Diagnostics, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial performance, operational changes, or market-moving news that would indicate a high risk.
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- August 7, 2025 (date) — Date of earliest event reported
- 001-41031 (company) — SEC File Number
- 47-3552922 (company) — I.R.S. Employer Identification No.
- 360 Massachusetts Avenue, Suite 203 (location) — Principal executive offices address
- Acton, MA 01720 (location) — Principal executive offices city, state, zip
- (844) 327-7078 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Bluejay Diagnostics, Inc.?
The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, and it concerns Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is August 7, 2025.
What is Bluejay Diagnostics, Inc.'s SEC File Number?
Bluejay Diagnostics, Inc.'s SEC File Number is 001-41031.
Where are Bluejay Diagnostics, Inc.'s principal executive offices located?
The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
What is the telephone number for Bluejay Diagnostics, Inc. as listed in the filing?
The registrant's telephone number, including area code, is (844) 327-7078.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-08-08 21:40:16
Filing Documents
- ea0252557-8k_bluejay.htm (8-K) — 25KB
- ea025255701ex99-1_bluejay.htm (EX-99.1) — 16KB
- image_001.jpg (GRAPHIC) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001213900-25-073870.txt ( ) — 252KB
- bjdx-20250807.xsd (EX-101.SCH) — 3KB
- bjdx-20250807_lab.xml (EX-101.LAB) — 33KB
- bjdx-20250807_pre.xml (EX-101.PRE) — 22KB
- ea0252557-8k_bluejay_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 7, 2025, following the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, Bluejay Diagnostics, Inc. issued a press release providing a 2025 second quarter business and corporate update. A copy of that press release is furnished with this report as Exhibit 99.1. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended ("Securities Act"), unless specifically identified therein as being incorporated by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits 99.1 Press release, dated August 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Bluejay Diagnostics, Inc. By: /s/ Neil Dey Neil Dey President and Chief Executive Officer Date: August 8, 2025 2